Do HIV-seropositive patients become colonised with drug-resistant microorganisms?

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 21, Issue 12, 2002, Pages 856-863

  Leegaard, T M ^a   Caugant, D A ^a   Froholm L O ^a   Hoiby E A ^a   Ronning E J ^b   Sandven, P ^a   Bruun, J N ^b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FLUCONAZOLE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CANDIDA; CANDIDIASIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MICROORGANISM; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036979899     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-002-0827-9     Document Type: Article

References (31)

1. Brettle R (1997) Bacterial infections in HIV: the extent and nature of the problem. Int J STD AIDS 8:5-15
2. Moellering RC Jr (1990) Interaction between antimicrobial consumption and selection of resistant bacterial strains. Scand J Infect Dis Suppl 70:18-24
3. Finkelstein DM, Williams PL, Molenberghs G, Feinberg J, Powderly WG, Kahn J, Dolin R, Cotton D (1996) Patterns of opportunistic infections in patients with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 12:38-45
4. Stein M, O'Sullivan P, Wachtel T, Fisher A, Mikolich D, Sepe S, Fort G, Carpenter C, Skowron G, Mayer K (1992) Causes of death in persons with human immunodeficiency virus infection. Am J Med 93:387-390
5. Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, Kvale PA, Markowitz N, Rosen MJ, Mangura BT, Hopewell PC (1995) Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 333:845-851
6. Leistevuo T, Leistevuo J, Osterblad M, Arvola T, Toivonen P, Klaukka T, Lehtonen A, Huovinen P (1996) Antimicrobial resistance of fecal aerobic gram-negative bacilli in different age groups in a community. Antimicrob Agents Chemother 40:1931-1934
7. Anonymous (2001) The HIV-situation in Norway as of December 31st 2000 (in Norwegian). MSIS-rapport (Communicable Disease Report Norway) 29:10
8. Kilian M (1991) Haemophilus. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ (eds) Manual of Clinical Microbiology. American Society for Microbiology, Washington DC, pp 463-470
9. Lassen J (1975) Rapid identification of gram-negative rods using a three-tube method combined with a dichotomic key. Acta Pathol Microbiol Scand [B] 83:525-533
10. Caugant DA, Levin BR, Selander RK (1981) Genetic diversity and temporal variation in the E. coli population of a human host. Genetics 98:467-490
11. Sandven P (1990) Laboratory identification and sensitivity testing of yeast isolates. Acta Odontol Scand 48:27-36
12. National Committee for Laboratory Standards (2001) Performance standards for antimicrobial susceptibility testing (M100-S11). NCCLS, Wayne, PA
13. Anonymous (2000) User's guide for Neo-sensitabs. In: Anonymous (ed) Neo-Sensitabs, susceptibility testing. A/S Rosco, Taastrup
14. Zerva L, Biedenbach DJ, Jones RN (1996) Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-μgram), imipenem (10-μgram), and ampicillin (2- and 10-μgram) disks. J Clin Microbiol 34:1970-1974
15. Shannon K, Phillips I (1980) β-Lactamase detection by three simple methods: intralactam, nitrocefin and acidimetric. J Antimicrob Chemother 6:617-621
16. Ørstavik I, Ødegaard K (1971) A simple test for penicillinase production in Staphylococcus aureus. Acta Pathol Microbiol Scand [B] 79:855-856
17. Bergan T, Bruun JN, Digranes A, Lingaas E, Melby KK, Sander J (1997) Susceptibility testing of bacteria and fungi. Report from "the Norwegian Working Group on Antibiotics". Scand J Infect Dis Suppl 103:1-36
18. National Committee for Clinical Laboratory Standards (1997) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard (M27-A). NCCLS, Wayne, PA
19. Sandven P (1999) Detection of fluconazole-resistant Candida strains by a disc diffusion screening test. J Clin Microbiol 37:3856-3859
20. Sandven P, Bevanger L, Digranes A, Gaustad P, Haukland HH, Steinbakk M (1998) Constant low rate of fungemia in Norway, 1991 to 1996. The Norwegian Yeast Study Group. J Clin Microbiol 36:3455-3459
21. Sandven P, Bjorneklett A, Maeland A (1993) Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group. Antimicrob Agents Chemother 37:2443-2448
22. Simonsen GS, Kruse H (eds) (2001) Consumption of antimicrobial agents and occurrence of antimicrobial resistance in Norway. NORM/NORM-VET, TromsøOslo
23. Kristiansen BE, Sandnes RA, Mortensen L, Tveten Y, Vorland L (2001) The prevalence of antibiotic resistance in bacterial respiratory pathogens from Norway is low. Clin Microbiol Infect 7:682-687
24. Leegaard TM, Vik E, Caugant DA, Frøholm LO, Høiby EA (1999) Low occurrence of antibiotic resistance in Escherichia coli and staphylococci isolated from blood cultures in two Norwegian hospitals in 1991-92 and 1995-96. APMIS 107:1060-1068
25. Leegaard TM, Bevanger L, Jureen R, Lier T, Melby KK, Caugant DA, Frøholm LO, Høiby EA (2001) Antibiotic sensitivity still prevails in Norwegian blood culture isolates. Int J Antimicrob Agents 18:99-106
26. Osterblad M, Hakanen A, Manninen R, Leistevuo T, Peltonen R, Meurman O, Huovinen P, Kotilainen P (2000) A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora. Antimicrob Agents Chemother 44:1479-1484
27. Elwell LP, Ferone R, Freeman GA, Fyfe JA, Hill JA, Ray PH, Richards CA, Singer SC, Knick VB, Rideout JL (1987) Antibacterial activity and mechanism of action of 3′-azido-3′-deoxythymidine (BW A509U). Antimicrob Agents Chemother 31:274-280
28. Meynard JL, Barbut F, Blum L, Guiguet M, Chouaid C, Meyohas MC, Picard O, Petit JC, Frottier J (1996) Risk factors for isolation of Streptococcus pneumoniae with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus. Clin Infect Dis 22:437-440
29. Sobel JD, Ohmit SE, Schuman P, Klein RS, Mayer K, Duerr A, Vazquez JA, Rampalo A (2001) The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 183:286-293
30. Davison HC, Low JC, Woolhouse ME (2000) What is antibiotic resistance and how can we measure it? Trends Microblol 8:554-559
31. Shanahan PM, Thomson CJ, Amyes SG (1994) Beta-lactam resistance in aerobic faecal flora from general practice patients in the UK. Eur J Clin Microbiol Infect Dis 13:760-763